BPC-157 is among the peptides that have drawn regulatory scrutiny because it has not undergone the FDA's drug approval process, meaning its risks and benefits have not been established through the rigorous clinical trials required for approved medications
So before anyone says otherwise, nobody pushed me into being trans
Medications Certain medications can turn urine shades of orange, red, and yellow
patients and prescribers can file at FDA MedWatch
Comparable observations have been noted in humans, with exogenous L-carnitine supplementation having a positive impact on immune mediators, showing its beneficial effects in preventing infection 5
ALN-2232: Dedicated RNAi program for obesity & weight management (Phase 1 data expected H2 2026) $4.9-$5.3B projected 2026 revenue, fueling aggressive expansion in metabolic and cardiometabolic pipelines 10+ tissue types & 40+ clinical programs targeted by 2030 ~30% of revenues reinvested into R&D, accelerating next-generation metabolic innovation Reinforces obesity's emergence as a foundational pillar of future medicine ------------------------------------------------------------- Stay up to date with everything obesity through my newsletter Todays popular weight-loss drugs (like Wegovy or Zepbound) are GLP-1 agonists
